Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks
regulatory fda clinical-trials

Lilly's New Pill: A Weight Loss Game-Changer?

Newsdesk profile image
by Newsdesk
Updated
Lilly's New Pill: A Weight Loss Game-Changer?

Eli Lilly's experimental GLP-1 pill, orforglipron, demonstrated significant weight loss results, according to a recent late-stage trial. Patients lost an average of 12.4% body weight over 72 weeks. However, this was below the 14.9% weight reduction a... [910 chars]

Newsdesk profile image
by Newsdesk
Updated

Be informed!

Rx.news delivers critical healthcare intelligence to pharmaceutical professionals, biotech innovators, healthcare investors, medical practitioners, and policy makers.

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More